Two New IL-1β Drugs Just Launched in China. What Firsekibart and Anfulitamab Mean for Gout
Two New IL-1β Drugs Just Launched in China. Here Is What They Mean for Gout Treatment Worldwide You probably have not heard of either of these drugs yet. Their names are firsekibart and anfulitamab, and both were approved in China over the past fourteen months for acute gout flares. They target IL-1β, the same inflammatory … Read more